Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.
نویسندگان
چکیده
BACKGROUND AND PURPOSE Anticoagulation reduces the risk of stroke in nonvalvular atrial fibrillation yet remains underused. We explored barriers to the use of anticoagulants among Australian family physicians. METHODS The authors conducted a representative, national survey. RESULTS Of the 596 (64.4%) eligible family physicians who participated, 15.8% reported having a patient with nonvalvular atrial fibrillation experience an intracranial hemorrhage with anticoagulation and 45.8% had a patient with known nonvalvular atrial fibrillation experience a stroke without anticoagulation. When presented with a patient at "very high risk" of stroke, only 45.6% of family physicians selected warfarin in the presence of a minor falls risk and 17.1% would anticoagulate if the patient had a treated peptic ulcer. Family physicians with less decisional conflict and longer-standing practices were more likely to endorse anticoagulation. CONCLUSIONS Strategies to optimize the management of nonvalvular atrial fibrillation should address psychological barriers to using anticoagulation.
منابع مشابه
فرآیند درمانی فیبریلاسیون دهلیزی در بیمارستان های ایران
Background: Lack of attention to standardized guidelines has caused tragic outcome in patients with atrial fibrillation and ultimately increase of financial burden imposed on the community structure of the economic system. Therefore, the present study was aimed to assess the exposure of patients with atrial fibrillation. Methods: A total of 506 patients with atrial fibrillation were...
متن کاملPhysicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
Numerous randomized controlled trials (RCTs) have conclusively demonstrated that long-term anticoagulation in patients with nonvalvular atrial fibrillation (NVAF) can reduce the risk of stroke by approximately 68% per year, with a low annual risk of major hemorrhage (1.3%). Despite these impressive results, several studies have shown that the use of warfarin in the “real world” for the preventi...
متن کاملRecent national patterns of warfarin use in atrial fibrillation.
BACKGROUND Studies of selected populations suggest that anticoagulation in atrial fibrillation is underused and that nonclinical factors influence the use of this stroke-preventing therapy. We wished to examine recent national trends and predictors of warfarin sodium use in atrial fibrillation. METHODS AND RESULTS A nationally representative sample of office visits from the 1989 to 1996 Natio...
متن کاملDirect oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide. Strokes that occur as a complication of AF are usually more severe and associated with a higher disability or morbidity and mortality rate compared with non-AF-related strokes. The risk of stroke in AF is dependent on several risk factors; AF itself acts as an independent risk factor for stroke. The combination of effecti...
متن کاملClinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations
The direct factor Xa inhibitor rivaroxaban was the first within the group of orally available direct factor Xa inhibitors to gain clinical approval for oral anticoagulation in patients with nonvalvular atrial fibrillation in 2011. The -xabans, as drugs from the group of oral direct factor Xa inhibitors are often referred to, comprise currently three drugs (apixaban, edoxaban, and rivaroxaban) w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Stroke
دوره 39 1 شماره
صفحات -
تاریخ انتشار 2008